Hydroxyurea to prevent brain injury in children with sickle cell disease (<scp>HU</scp> Prevent)—A randomized, placebo‐controlled phase <scp>II</scp> feasibility/pilot study - KIVIRID

Hydroxyurea to prevent brain injury in children with sickle cell disease (<scp>HU</scp> Prevent)—A randomized, placebo‐controlled phase <scp>II</scp> feasibility/pilot study

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/10.1002/ajh.27423

Keywords:

Abstract:

Source: